ArticleBMC cancer2026

FGFR4-high expression is associated with an immune-responsive phenotype in HCC and predicts inferior efficacy of lenvatinib plus PD-1 blockade.

Fuqun Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.